MV Lifesciences

Rixensart ·KBO/BCE: BE 0781.705.776

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	18-08-2025	18 d late	2025-00384413
31-12-2023	31-07-2024	29-07-2024	2 d early	2024-00322135
31-12-2022	31-07-2023	10-08-2023	10 d late	2023-00326199

Metric	This company	Sector median	Position in the sector
Solvency	76.3%	53.8%	better than 78% of 3178 sector peers
Net result	€150k	€18k	better than 95% of 3177 sector peers
Equity	€256k	€40k	better than 93% of 3180 sector peers
Gross operating margin	€207k	€36k	better than 95% of 3177 sector peers
Total assets	€336k	€94k	better than 86% of 3183 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€336k
Fixed assets	21/28	€75k
Tangible fixed assets	22/27	€6k
Financial fixed assets	28	€69k
Current assets	29/58	€261k
Amounts receivable within one year	40/41	€236k
Cash & bank	54/58	€24k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€336k
Equity	10/15	€256k
Contributions / capital	10/11	€20k
Reserves	13	€15k
Accumulated profits (losses)	14	€221k
Amounts payable	17/49	€79k
Amounts payable within one year	42/48	€79k
Trade debts payable within one year	44	€4k
Income statement
Gross operating margin	9900	€207k
Operating result	9901	€201k
Financial income	75	€9k
Financial charges	65	€465
Result before taxes	9903	€210k
Income taxes	67/77	€60k
Net result for the period	9904	€150k
Result to be appropriated	9905	€150k

Summary

NACE primary	Overige zakelijke dienstverlening, neg(82990)
Legal form	Private limited company(610)
Incorporation	08-02-2022
Status	Active
Postal code	1331